Clinical trial
Randomized Trial of ARCON in Larynx Cancer
NCT00147732 · Radboud University Medical Center, Other · Completed
Key facts
| NCT number | NCT00147732 |
|---|---|
| Title | Randomized Trial of ARCON in Larynx Cancer |
| Official title | A Multicentre, Randomised, Phase III Clinical Trial Comparing Accelerated Radiotherapy With Accelerated Radiotherapy Plus Carbogen and Nicotinamide (ARCON) in Clinical Stage T2-4 Laryngeal Carcinoma. |
| Lead sponsor | Radboud University Medical Center, Other |
| Collaborators | Dutch Cancer Society |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Larynx Carcinoma |
| Intervention type | Radiation |
| Interventions | Accelerated radiotherapy, ARCON |
| Enrollment | 345 |
| Start date | Apr 1, 2001 |
| Primary completion | Feb 1, 2008 |
| Completion | Apr 1, 2013 |
| First posted | Sep 7, 2005 |
| Last update posted | May 7, 2015 |
| Countries | Netherlands, United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: